Una revisione sistematica della conoscenza delle donne sullo screening mammografico

    Publication Date
    Source Authors
    Source Title
    Source Issue
    Publication Date

    2018

    Source Authors

    Kristen Seaman, Peta L. Dzidic, Emily Castell, Christobel Saunders, Lauren J. Breen

    Source Title

    Una revisione sistematica della conoscenza delle donne sullo screening mammografico

    Source Issue

    The Breast

    42

    Page Range: 81-93

    Alla luce della contesa che circonda il rapporto beneficio-danno della mammografia di screening, questo articolo mira a comprendere le conoscenze delle donne riguardo la mammografia di screening. La ricerca ha prodotto 35 studi di varie metodologie, pubblicati / completati tra il 1992 e il 2017. I risultati dello studio suggeriscono che la maggior parte delle donne è a conoscenza dello screening, tuttavia c’era una grande variabilità riguardo alla consapevolezza di falsi positivi / negativi e riguardo allo scopo dello screening. Alcuni argomenti (ad es. Radiazioni, età di inizio) sono ben compresi dalle donne; tuttavia, altri non lo sono (ad es. età di cessazione, diagnosi eccessiva e riduzione della mortalità). Il carcinoma mammario è il tumore femminile più comunemente diagnosticato in tutto il mondo. The International Cancer Screening Network (ICSN) è un consorzio di 27 paesi che hanno programmi di screening del carcinoma mammario in tutta la popolazione. Sebbene lo screening mammografico è la tecnica più accurata per la diagnosi del cancro al seno, vi sono preoccupazioni per il rapporto beneficio-danno alle donne asintomatiche. Lo scopo principale del lavoro è quello di verificare effettivamente cosa le donne sanno riguardo lo screening mammografico e identificare i pro e i contro. I potenziali benefici dello screening mammografico comprendono; diagnosi precoce, maggiori opzioni di trattamento e trattamento meno invasivo, opportunità di chirurgia per conservare il seno e miglioramento della sopravvivenza e rassicurazione quando l’esame è negativo. Tutti i benefici dovrebbero essere contrapposti ai falsi positivi o ai danni da eccessiva diagnosi che portano le donne ad eseguire ulteriori esami pur presentando una diagnosi negativa. Questi studi suggeriscono che molte donne non hanno una comprensione accurata dei benefici / danni imposti dallo screening, questa ricerca mira a essere il primo studio a rivedere sistematicamente la letteratura sulla conoscenza delle donne riguardo lo screening. L’ articolo si suddivide in vari punti. Nella prima parte abbiamo l’introduzione dell’argomento che verrà trattato successivamente si sofferma sulla ricerca effettuata e i relativi risultati.

    BIBLIOGRAFIA

    1. World Health Organization. WHO position paper on mammography screening. World Health Organization; 2014. Retrieved from, http://apps.who. int/iris/bitstream/10665/137339/1/9789241507936_eng.pdf.
    2. Lauby-Secretan B, Scoccianti C, Loomis D, Benbrahim-Tallaa L, Bouvard V, Bianchini F, Straif K. Breast-cancer screeningdviewpoint of the IARC working group. N Engl J Med 2015;372(24):2353e8.
    3. Gøtzsche PC, Jørgensen KJ. Screening for breast cancer with mammography. Cochrane Database Syst Rev 2013;6(6). https://doi.org/10.1002/14651858.CD001877.pub2.
    4. Morris E, Feig SA, Drexler M, Lehman C. Implications of overdiagnosis: impact on screening mammography practices. Popul Health Manag 2015;18(Suppl 1). https://doi.org/10.1089/pop.2015.29023.mor. S-3-S-11.
    5. Armstrong K, Moye E, Williams S, Berlin JA, Reynolds EE. Screening mammography in women 40 to 49 years of age: a systematic review for the American College of Physicians. Ann Intern Med 2007;146(7):516e26. https://doi.org/10.7326/0003-4819-146-7-200704030-00008.
    6. Australian Institute of Health and Welfare. BreastScreen Australia monitoring report 2012e2013. Canberra: Author; 2015 (Cancer series no. 95. Cat. no. CAN 93).
    7. Griffiths F, Bendelow G, Green E, Palmer J. Screening for breast cancer: medicalization, visualization and the embodied experience. Health: Interdiscipl J Soc Stud Health Ill Med 2010;14(6):653e68. https://doi.org/10.1177/1363459310361599.
    8. Pace LE, Keating NL. A systematic assessment of benefits and risks to guide breast cancer screening decisions. J Am Med Assoc 2014;311(13):1327e35. https://doi.org/10.1001/jama.2014.1398.
    9. Mathieu E, Barratt AL, McGeechan K, Davey HM, Howard K, Houssami N. Helping women make choices about mammography screening: an online randomized trial of a decision aid for 40-year-old women. Patient Educ Counsel 2010;81(1):63e72. https://doi.org/10.1016/j.pec.2010.01.001.
    10. Nelson HD, Fu R, Cantor A, Pappas M, Daeges M, Humphrey L. Effectiveness of breast cancer screening: systematic review and meta-analysis to update the 2009 US Preventive Services Task Force recommendation. Ann Intern Med 2016;164(4):244e55. https://doi.org/10.7326/M15-0969.
    11. Siu AL. Screening for breast cancer: US preventive services task force recommendation statement. Ann Intern Med 2016;164(4):279e96. https://doi.org/10.7326/m15-2886.
    12. Marmot M, Altman D, Cameron D, et al. The benefits and harms of breast cancer screening: an independent review. Br J Canc 2013;108:2205e40. https://doi.org/10.1016/s0140-6736(12)61611-0.
    13. Jørgensen KJ, Gøtzsche PC. Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends. BMJ 2009;339, b2587. https://doi.org/10.1136/bmj.b2587.
    14. Brodersen J, Siersma VD. Long-term psychosocial consequences of false positive screening mammography. Ann Fam Med 2013;11(2):106e15. https://doi.org/10.1370/afm.1466.
    15. Salz T, Richman AR, Brewer NT. Meta-analyses of the effect of false- positive mammograms on generic and specific psychosocial outcomes. Psycho Oncol 2010;19(10):1026e34. https://doi.org/10.1002/pon.1676.
    16. Tosteson AN, Fryback DG, Hammond CS, Hanna LG, Grove MR, Brown M, …,Pisano ED. Consequences of false-positive screening mammograms. JAMA Int Med 2014;174(6):954e61. https://doi.org/10.1001/jamainternmed.2014.981.
    17. Yaffe MJ, Mainprize JG. Risk of radiation-induced breast cancer from mammographic screening 1. Radiology 2011;258(1):98e105. https://doi.org/10.1148/radiol.10100655.
    18. Chamot E, Perneger TV. Misconceptions about efficacy of mammography screening: a public health dilemma. J Epidemiol Community Health 2001;55(11):799e803. https://doi.org/10.1136/jech.55.11.799.
    19. Domenighetti G, D’Avanzo B, Egger M, Berrino F, Perneger T, Mosconi P, Zwahlen M. Women’s perception of the benefits of mammography screening: population-based survey in four countries. Int J Epidemiol 2003;32(5):816e21. https://doi.org/10.1093/ije/dyg257.
    20. Webster P, Austoker J. Women’s knowledge about breast cancer risk and their views of the purpose and implications of breast screeningda questionnaire survey. J Public Health 2006;28(3):197e202. https://doi.org/10.1093/pubmed/fdl030.
    21. Woloshin S, Schwartz LM, Byram SJ, Sox HC, Fischhoff B, Welch HG. Women’s understanding of the mammography screening debate. Arch Intern Med 2000;160(10):1434e40. https://doi.org/10.1001/archinte.160.10.1434.
    22. Hersch J, Barratt A, Jansen J, Irwig L, McGeechan K, Jacklyn G, …, McCaffery K. Use of a decision aid including information on overdetection to support informed choice about breast cancer screening: a randomised controlled trial. Lancet 2015;385(9978):1642e52. https://doi.org/10.1016/S0140-6736(15)60123-4.
    23. Hersch J, Jansen J, Barratt A, Irwig L, Houssami N, Jacklyn G, …, McCaffery K. Overdetection in breast cancer screening: development and preliminary evaluation of a decision aid. BMJ Open 2014;4(9):e006016. https://doi.org/10.1136/bmjopen-2014-006016.
    24. Waller J, Douglas E, Whitaker KL, Wardle J. Women ‘s responses to information about overdiagnosis in the UK breast cancer screening programme: a qualitative study. BMJ Open 2013;3(4). https://doi.org/10.1136/bmjopen2013-002703.
    25. Hersch J, Jansen J, Irwig L, Barratt A, Thornton H, Howard K, McCaffery K. Howdo we achieve informed choice for women considering breast screening? Prev Med 2011;53(3):144e6. https://doi.org/10.1016/j.ypmed.2011.06.013.
    26. Mathieu E, Barratt A, Davey HM, McGeechan K, Howard K, Houssami N. Informed choice in mammography screening: a randomized trial of a decision aid for 70-year-old women. Arch Intern Med 2007;167(19):2039e46. https://doi.org/10.1001/archinte.167.19.2039.
    27. Smith SK, Trevena L, Simpson JM, Barratt A, Nutbeam D, McCaffery KJ.A decision aid to support informed choices about bowel cancer screening among adults with low education: randomised controlled trial. BMJ 2010;341.https://doi.org/10.1136/bmj.c537.
    28. Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, Stewart LA. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev 2015;4(1):1. https://doi.org/10.1136/bmj.i4086.
    29. Kmet L, Lee R, Cook L. Standard quality assessment criteria for evaluating primary research papers from a variety of fields. 2004. Retrieved from https://www.biomedcentral.com/content/supplementary/1471-2393-14-52-s2.pdf.
    30. Lee L, Packer TL, Tang SH, Girdler S. Self-management education programs for age-related macular degeneration: a systematic review. Australas J Ageing 2008;27(4):170e6. https://doi.org/10.1111/j.1741-6612.2008.00298.x.
    31. Popay J, Roberts H, Sowden A, Petticrew M, Arai L, Rodgers M, …, Duffy S. Guidance on the conduct of narrative synthesis in systematic reviews: a product from the ESRC Methods Programme. Lancaster University; 2006.
    32. Achat H, Close G, Taylor R. Who has regular mammograms? Effects of knowledge, beliefs, socioeconomic status, and health-related factors. Prev Med 2005;41(1):312e20. https://doi.org/10.1016/j.ypmed.2004.11.016.
    33. Baena-Canada JM, Rosado-Varela P, Exposito-Alvarez I, Gonzalez-Guerrero M, Nieto-Vera J, Benitez-Rodriguez E. Women’s perceptions of breast cancer screening. Spanish screening programme survey. Breast 2014;23(6):883e8. https://doi.org/10.1016/j.breast.2014.09.010.
    34. Banning M. Perceptions of breast health awareness in Black British women. Eur J Oncol Nurs 2011;15(2):173e7. https://doi.org/10.1016/j.ejon.2010.07.007.
    35. Barratt A, Cockburn J, Furnival C, McBride A, Mallon L. Perceived sensitivity of mammographic screening: women’s views on test accuracy and financial compensation for missed cancers. J Epidemiol Community Health 1999;53(11):716e20. https://doi.org/10.1136/jech.53.11.716.
    36. Barratt AL, Cockburn J, Redman S, Paul C, Perkins J. Mammographic screening: results from the 1996 national breast health survey. Med J Aust 1997;167(10):521e4. Retrieved from, http://europepmc.org/abstract/med/9397038.
    37. Berens E-M, Reder M, Razum O, Kolip P, Spallek J. Informed choice in the German Mammography Screening Program by education and migrant status: survey among first-time invitees. PLoS One 2015;10(11), e0142316. https://doi.org/10.1371/journal.pone.0142316.
    38. Berens EM, Yilmaz-Aslan Y, Spallek J, Razum O. Determinants of mammography screening participation among Turkish immigrant women in Germanyea qualitative study reflecting key informants’ and women’s perspectives. Eur J Canc Care 2016;25(1):38e48. https://doi.org/10.1111/ecc.12334.
    39. Chamot E, Charvet AI, Perneger TV. Who gets screened, and where: a comparison of organised and opportunistic mammography screening in Geneva, Switzerland. Eur J Canc 2007;43(3):576e84. https://doi.org/10.1016/j.ejca.2006.10.017.
    40. Chouliara Z, Power KG, Swanson V, Johnstone F. Factors associated with breast screening attendance: a controlled comparison between attenders and 92 K. Seaman et al. / The Breast 42 (2018) 81e93 nonattenders in Scotland. Int J Health Promot Educ 2002;40(3):78e90. https://doi.org/10.1080/14635240.2002.10806203.
    41. Cockburn J, Redman S, Hill D, Henry E. Public understanding of medical screening. J Med Screen 1995;2(4):224e7. https://doi.org/10.1177/096914139500200410.
    42. Cockburn J, Pit S, Redman S. Perceptions of screening mammography among women aged 40-49. Aust N Z J Publ Health 1999;23(3):318e21. https://doi.org/10.1111/j.1467-842x.1999.tb01264.x.
    43. Ferrat E, Le Breton J, Djassibel M, Veerabudun K, Brixi Z, Attali C, Renard V. Understanding barriers to organized breast cancer screening in France: women’s perceptions, attitudes, and knowledge. Fam Pract 2013;30(4):445e51. https://doi.org/10.1093/fampra/cmt004.
    44. Ham OK. Factors affecting mammography behavior and intention among Korean women. Oncol Nurs Forum 2006;33(1):113e9. https://doi.org/10.1188/06.onf.113-119.
    45. Henriksen MJV, Guassora AD, Brodersen J. Preconceptions influence women’s perceptions of information on breast cancer screening: a qualitative study. BMC Res Notes 2015;8(1). https://doi.org/10.1186/s13104-015-1327-1.
    46. Hersch J, Jansen J, Barratt A, Irwig L, Houssami N, Howard K, …, McCaffery K. Women’s views on overdiagnosis in breast cancer screening: a qualitative study. BMJ (Clinical research ed.) 2013;346:1. https://doi.org/10.1136/bmj.f158.
    47. Hippman C, Moshrefzadeh A, Lohn Z, Hodgson ZG, Dewar K, Lam M, …, Kwong J. Breast cancer and mammography screening: knowledge, beliefs and predictors for Asian immigrant women attending a specialized clinic in British Columbia, Canada. J Immigr Minority Health 2015;18(6):1441e8. https://doi.org/10.1007/s10903-015-0332-8.
    48. Kissal A, Beser A. Knowledge, facilitators and perceived barriers for early detection of breast cancer among elderly Turkish women. Asian Pac J Cancer Prev APJCP 2011;12(4):975e84. Retrieved from, https://www.ncbi.nlm.nih.gov/pubmed/21790237.
    49. Kwok C, Lim D. Evaluation of a culturally tailored education to promote breast and cervical cancer screening among Chinese-Australian women. J Canc Educ 2015;31(3):595e601. https://doi.org/10.1007/s13187-015-0859-3.
    50. Lagerlund M, Widmark C, Lambe M, Tishelman C. Rationales for attending or not attending mammography screening – a focus group study among women in Sweden. Eur J Canc Prev 2001;10(5):429e42. https://doi.org/10.1097/00008469-200110000-00007.
    51. Mah Z, Bryant H. Age as a factor in breast cancer knowledge, attitudes and screening behaviour. CMAJ (Can Med Assoc J): Can Med Assoc J 1992;146(12):2167.
    52. Luengo-Matos S, Polo-Santos M, Saz-Parkinson Z. Mammography use and factors associated with its use after the introduction of breast cancer screening programmes in Spain. Eur J Canc Prev 2006;15(3):242e8. https://doi.org/10.1097/01.cej.0000199503.30818.e6.
    53. Nembhard KTA. Knowledge of overdiagnosis and the decision to participate in breast cancer screening (Doctoral dissertation, Walden University). 2015. Retrieved from, http://scholarworks.waldenu.edu/cgi/viewcontent.cgi?article%1466&context%dissertations.
    54. Reder M, Kolip P. Does a decision aid improve informed choice in ammography screening? Results from a randomised controlled trial. PLoS One 2017;12(12), e0189148. https://doi.org/10.1371/journal.pone.0189148.
    55. Sommer R, Dirmaier J, Fechtelpeter D, Koch K, Hearter M, Bergelt C. Development of a decision tool for mammography screening. Onkologe 2016;22(8):578e85. Retrieved from, https://link.springer.com/article/10.1007/s00761-016-0081-x.
    56. Soskolne V, Marie S, Manor O. Beliefs, recommendations and intentions are important explanatory factors of mammography screening behavior among Muslim Arab women in Israel. Health Educ Res 2006;22(5):665e76. https://doi.org/10.1093/her/cyl132.
    57. van Agt H, Fracheboud J, van der Steen A, de Koning H. Do women make an informed choice about participating in breast cancer screening? A survey among women invited for a first mammography screening examination. Patient Educ Counsel 2012;89(2):353e9. https://doi.org/10.1016/j.pec.2012.08.003.
    58. Villanueva EV, Jones S, Nehill C, Favelle S, Steel D, Iverson D, Zorbas H. The 2003 Australian Breast Health Survey: survey design and preliminary results. BMC Publ Health 2008;8:13. https://doi.org/10.1186/1471-2458-8-13.
    59. Waller J, Whitaker KL, Winstanley K, Power E, Wardle J. A survey study of women’s responses to information about overdiagnosis in breast cancer screening in Britain. Br J Canc 2014;111(9):1831e5. https://doi.org/10.1038/bjc.2014.482.
    60. Al-Dubai SA, Qureshi AM, Saif-Ali R, Ganasegeran K, Alwan MR, Hadi JI. Awareness and knowledge of breast cancer and mammography among a group of Malaysian women in Shah Alam. Asian Pac J Cancer Prev APJCP 2011;12(10):2531e8. Retrieved from, http://apepressco.com/APJCP_Issues.php.
    61. King ES, Resch N, Rimer B, Lerman C, Boyce A, McGoverngorchov P. Breast cancer screening practices among retirement community women. Prev Med 1993;22(1):1e19. https://doi.org/10.1006/pmed.1993.1001.
    62. Sim HL, Seah M, Tan SM. Breast cancer knowledge and screening practices: a survey of 1,000 Asian women. Singap Med J 2009;50(2):132. Retrieved from, https://pdfs.semanticscholar.org/6bc0/9634124516a19112fb54c267d40bbbdbd7f9.pdf.
    63. Lagerlund M, Hedin A, Sparen P, Thurfjell E, Lambe M. Attitudes, beliefs, and knowledge as predictors of nonattendance in a Swedish population-based mammography screening program. Prev Med 2000;31(4):417e28. https:// doi.org/10.1006/pmed.2000.0723.
    64. Nekhlyudov L, Li R, Fletcher SW. Informed decision making before initiating screening mammography: does it occur and does it make a difference? Health Expect: Int J Public Part Health Care Health Policy 2008;11(4):366e75. https://doi.org/10.1111/j.1369-7625.2008.00514.x.
    65. Jørgensen KJ, Gøtzsche PC. Presentation on websites of possible benefits and harms from screening for breast cancer: cross sectional study. BMJ2004;328(7432):148. https://doi.org/10.1136/bmj.328.7432.148.
    66. Amoran O, Toyobo T, Fatugase O. Breast cancer screening awareness and practice among women in Sagamu local government area, South-Western Nigeria: a community based study. Br J Appl Sci Technol 2014;4(16):2320. https://doi.org/10.9734/bjast/2014/9050.
    67. Peppercorn J, Houck K, Beri N, Villagra V, Wogu AF, Lyman GH, Wheeler SB. Breast cancer screening utilization and understanding of current guidelines among rural US women with private insurance. Breast Canc Res Treat 2015;153(3):659e67. https://doi.org/10.1007/s10549-015-3566-1.
    68. McNair Ingenuity Research group. Campaign evaluation BreastScreen Australia. 2015. Retrieved from, http://www.cancerscreening.gov.au/internet/screening/publishing.nsf/Content/D2F8355B3C9C3107CA257E1A007D9F71/$File/BreastScreen%20Eval%20Report.pdf.
    69. Shapiro S, Venet W, Strax P, Venet L, Roeser R. Selection, follow-up, and analysis in the Health Insurance Plan Study: a randomized trial with breast cancer screening. Natl Canc Inst Monogr 1985;67:65e74. Retrieved from, http://europepmc.org/abstract/med/4047153.
    70. Bleyer A, Welch HG. Effect of three decades of screening mammography on breast-cancer incidence. N Engl J Med 2012;367(21):1998e2005. https://doi.org/10.1056/NEJMoa1206809.
    71. Ghanouni A, Renzi C, Meisel SF, Waller J. Common methods of measuring “informed choice” in screening participation: challenges and future directions. Prevent Med Rep 2016;4:601e7. https://doi.org/10.1016/j.pmedr.2016.10.017.
    1. World Health Organization. WHO position paper on mammography screening. World Health Organization; 2014. Retrieved from, http://apps.who. int/iris/bitstream/10665/137339/1/9789241507936_eng.pdf.
    2. Lauby-Secretan B, Scoccianti C, Loomis D, Benbrahim-Tallaa L, Bouvard V, Bianchini F, Straif K. Breast-cancer screeningdviewpoint of the IARC working group. N Engl J Med 2015;372(24):2353e8.
    3. Gøtzsche PC, Jørgensen KJ. Screening for breast cancer with mammography. Cochrane Database Syst Rev 2013;6(6). https://doi.org/10.1002/14651858.CD001877.pub2.
    4. Morris E, Feig SA, Drexler M, Lehman C. Implications of overdiagnosis: impact on screening mammography practices. Popul Health Manag 2015;18(Suppl 1). https://doi.org/10.1089/pop.2015.29023.mor. S-3-S-11.
    5. Armstrong K, Moye E, Williams S, Berlin JA, Reynolds EE. Screening mammography in women 40 to 49 years of age: a systematic review for the American College of Physicians. Ann Intern Med 2007;146(7):516e26. https://doi.org/10.7326/0003-4819-146-7-200704030-00008.
    6. Australian Institute of Health and Welfare. BreastScreen Australia monitoring report 2012e2013. Canberra: Author; 2015 (Cancer series no. 95. Cat. no. CAN 93).
    7. Griffiths F, Bendelow G, Green E, Palmer J. Screening for breast cancer: medicalization, visualization and the embodied experience. Health: Interdiscipl J Soc Stud Health Ill Med 2010;14(6):653e68. https://doi.org/10.1177/1363459310361599.
    8. Pace LE, Keating NL. A systematic assessment of benefits and risks to guide breast cancer screening decisions. J Am Med Assoc 2014;311(13):1327e35. https://doi.org/10.1001/jama.2014.1398.
    9. Mathieu E, Barratt AL, McGeechan K, Davey HM, Howard K, Houssami N. Helping women make choices about mammography screening: an online randomized trial of a decision aid for 40-year-old women. Patient Educ Counsel 2010;81(1):63e72. https://doi.org/10.1016/j.pec.2010.01.001.
    10. Nelson HD, Fu R, Cantor A, Pappas M, Daeges M, Humphrey L. Effectiveness of breast cancer screening: systematic review and meta-analysis to update the 2009 US Preventive Services Task Force recommendation. Ann Intern Med 2016;164(4):244e55. https://doi.org/10.7326/M15-0969.
    11. Siu AL. Screening for breast cancer: US preventive services task force recommendation statement. Ann Intern Med 2016;164(4):279e96. https://doi.org/10.7326/m15-2886.
    12. Marmot M, Altman D, Cameron D, et al. The benefits and harms of breast cancer screening: an independent review. Br J Canc 2013;108:2205e40. https://doi.org/10.1016/s0140-6736(12)61611-0.
    13. Jørgensen KJ, Gøtzsche PC. Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends. BMJ 2009;339, b2587. https://doi.org/10.1136/bmj.b2587.
    14. Brodersen J, Siersma VD. Long-term psychosocial consequences of false positive screening mammography. Ann Fam Med 2013;11(2):106e15. https://doi.org/10.1370/afm.1466.
    15. Salz T, Richman AR, Brewer NT. Meta-analyses of the effect of false- positive mammograms on generic and specific psychosocial outcomes. Psycho Oncol 2010;19(10):1026e34. https://doi.org/10.1002/pon.1676.
    16. Tosteson AN, Fryback DG, Hammond CS, Hanna LG, Grove MR, Brown M, …,Pisano ED. Consequences of false-positive screening mammograms. JAMA Int Med 2014;174(6):954e61. https://doi.org/10.1001/jamainternmed.2014.981.
    17. Yaffe MJ, Mainprize JG. Risk of radiation-induced breast cancer from mammographic screening 1. Radiology 2011;258(1):98e105. https://doi.org/10.1148/radiol.10100655.
    18. Chamot E, Perneger TV. Misconceptions about efficacy of mammography screening: a public health dilemma. J Epidemiol Community Health 2001;55(11):799e803. https://doi.org/10.1136/jech.55.11.799.
    19. Domenighetti G, D’Avanzo B, Egger M, Berrino F, Perneger T, Mosconi P, Zwahlen M. Women’s perception of the benefits of mammography screening: population-based survey in four countries. Int J Epidemiol 2003;32(5):816e21. https://doi.org/10.1093/ije/dyg257.
    20. Webster P, Austoker J. Women’s knowledge about breast cancer risk and their views of the purpose and implications of breast screeningda questionnaire survey. J Public Health 2006;28(3):197e202. https://doi.org/10.1093/pubmed/fdl030.
    21. Woloshin S, Schwartz LM, Byram SJ, Sox HC, Fischhoff B, Welch HG. Women’s understanding of the mammography screening debate. Arch Intern Med 2000;160(10):1434e40. https://doi.org/10.1001/archinte.160.10.1434.
    22. Hersch J, Barratt A, Jansen J, Irwig L, McGeechan K, Jacklyn G, …, McCaffery K. Use of a decision aid including information on overdetection to support informed choice about breast cancer screening: a randomised controlled trial. Lancet 2015;385(9978):1642e52. https://doi.org/10.1016/S0140-6736(15)60123-4.
    23. Hersch J, Jansen J, Barratt A, Irwig L, Houssami N, Jacklyn G, …, McCaffery K. Overdetection in breast cancer screening: development and preliminary evaluation of a decision aid. BMJ Open 2014;4(9):e006016. https://doi.org/10.1136/bmjopen-2014-006016.
    24. Waller J, Douglas E, Whitaker KL, Wardle J. Women ‘s responses to information about overdiagnosis in the UK breast cancer screening programme: a qualitative study. BMJ Open 2013;3(4). https://doi.org/10.1136/bmjopen2013-002703.
    25. Hersch J, Jansen J, Irwig L, Barratt A, Thornton H, Howard K, McCaffery K. Howdo we achieve informed choice for women considering breast screening? Prev Med 2011;53(3):144e6. https://doi.org/10.1016/j.ypmed.2011.06.013.
    26. Mathieu E, Barratt A, Davey HM, McGeechan K, Howard K, Houssami N. Informed choice in mammography screening: a randomized trial of a decision aid for 70-year-old women. Arch Intern Med 2007;167(19):2039e46. https://doi.org/10.1001/archinte.167.19.2039.
    27. Smith SK, Trevena L, Simpson JM, Barratt A, Nutbeam D, McCaffery KJ.A decision aid to support informed choices about bowel cancer screening among adults with low education: randomised controlled trial. BMJ 2010;341.https://doi.org/10.1136/bmj.c537.
    28. Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, Stewart LA. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev 2015;4(1):1. https://doi.org/10.1136/bmj.i4086.
    29. Kmet L, Lee R, Cook L. Standard quality assessment criteria for evaluating primary research papers from a variety of fields. 2004. Retrieved from https://www.biomedcentral.com/content/supplementary/1471-2393-14-52-s2.pdf.
    30. Lee L, Packer TL, Tang SH, Girdler S. Self-management education programs for age-related macular degeneration: a systematic review. Australas J Ageing 2008;27(4):170e6. https://doi.org/10.1111/j.1741-6612.2008.00298.x.
    31. Popay J, Roberts H, Sowden A, Petticrew M, Arai L, Rodgers M, …, Duffy S. Guidance on the conduct of narrative synthesis in systematic reviews: a product from the ESRC Methods Programme. Lancaster University; 2006.
    32. Achat H, Close G, Taylor R. Who has regular mammograms? Effects of knowledge, beliefs, socioeconomic status, and health-related factors. Prev Med 2005;41(1):312e20. https://doi.org/10.1016/j.ypmed.2004.11.016.
    33. Baena-Canada JM, Rosado-Varela P, Exposito-Alvarez I, Gonzalez-Guerrero M, Nieto-Vera J, Benitez-Rodriguez E. Women’s perceptions of breast cancer screening. Spanish screening programme survey. Breast 2014;23(6):883e8. https://doi.org/10.1016/j.breast.2014.09.010.
    34. Banning M. Perceptions of breast health awareness in Black British women. Eur J Oncol Nurs 2011;15(2):173e7. https://doi.org/10.1016/j.ejon.2010.07.007.
    35. Barratt A, Cockburn J, Furnival C, McBride A, Mallon L. Perceived sensitivity of mammographic screening: women’s views on test accuracy and financial compensation for missed cancers. J Epidemiol Community Health 1999;53(11):716e20. https://doi.org/10.1136/jech.53.11.716.
    36. Barratt AL, Cockburn J, Redman S, Paul C, Perkins J. Mammographic screening: results from the 1996 national breast health survey. Med J Aust 1997;167(10):521e4. Retrieved from, http://europepmc.org/abstract/med/9397038.
    37. Berens E-M, Reder M, Razum O, Kolip P, Spallek J. Informed choice in the German Mammography Screening Program by education and migrant status: survey among first-time invitees. PLoS One 2015;10(11), e0142316. https://doi.org/10.1371/journal.pone.0142316.
    38. Berens EM, Yilmaz-Aslan Y, Spallek J, Razum O. Determinants of mammography screening participation among Turkish immigrant women in Germanyea qualitative study reflecting key informants’ and women’s perspectives. Eur J Canc Care 2016;25(1):38e48. https://doi.org/10.1111/ecc.12334.
    39. Chamot E, Charvet AI, Perneger TV. Who gets screened, and where: a comparison of organised and opportunistic mammography screening in Geneva, Switzerland. Eur J Canc 2007;43(3):576e84. https://doi.org/10.1016/j.ejca.2006.10.017.
    40. Chouliara Z, Power KG, Swanson V, Johnstone F. Factors associated with breast screening attendance: a controlled comparison between attenders and 92 K. Seaman et al. / The Breast 42 (2018) 81e93 nonattenders in Scotland. Int J Health Promot Educ 2002;40(3):78e90. https://doi.org/10.1080/14635240.2002.10806203.
    41. Cockburn J, Redman S, Hill D, Henry E. Public understanding of medical screening. J Med Screen 1995;2(4):224e7. https://doi.org/10.1177/096914139500200410.
    42. Cockburn J, Pit S, Redman S. Perceptions of screening mammography among women aged 40-49. Aust N Z J Publ Health 1999;23(3):318e21. https://doi.org/10.1111/j.1467-842x.1999.tb01264.x.
    43. Ferrat E, Le Breton J, Djassibel M, Veerabudun K, Brixi Z, Attali C, Renard V. Understanding barriers to organized breast cancer screening in France: women’s perceptions, attitudes, and knowledge. Fam Pract 2013;30(4):445e51. https://doi.org/10.1093/fampra/cmt004.
    44. Ham OK. Factors affecting mammography behavior and intention among Korean women. Oncol Nurs Forum 2006;33(1):113e9. https://doi.org/10.1188/06.onf.113-119.
    45. Henriksen MJV, Guassora AD, Brodersen J. Preconceptions influence women’s perceptions of information on breast cancer screening: a qualitative study. BMC Res Notes 2015;8(1). https://doi.org/10.1186/s13104-015-1327-1.
    46. Hersch J, Jansen J, Barratt A, Irwig L, Houssami N, Howard K, …, McCaffery K. Women’s views on overdiagnosis in breast cancer screening: a qualitative study. BMJ (Clinical research ed.) 2013;346:1. https://doi.org/10.1136/bmj.f158.
    47. Hippman C, Moshrefzadeh A, Lohn Z, Hodgson ZG, Dewar K, Lam M, …, Kwong J. Breast cancer and mammography screening: knowledge, beliefs and predictors for Asian immigrant women attending a specialized clinic in British Columbia, Canada. J Immigr Minority Health 2015;18(6):1441e8. https://doi.org/10.1007/s10903-015-0332-8.
    48. Kissal A, Beser A. Knowledge, facilitators and perceived barriers for early detection of breast cancer among elderly Turkish women. Asian Pac J Cancer Prev APJCP 2011;12(4):975e84. Retrieved from, https://www.ncbi.nlm.nih.gov/pubmed/21790237.
    49. Kwok C, Lim D. Evaluation of a culturally tailored education to promote breast and cervical cancer screening among Chinese-Australian women. J Canc Educ 2015;31(3):595e601. https://doi.org/10.1007/s13187-015-0859-3.
    50. Lagerlund M, Widmark C, Lambe M, Tishelman C. Rationales for attending or not attending mammography screening – a focus group study among women in Sweden. Eur J Canc Prev 2001;10(5):429e42. https://doi.org/10.1097/00008469-200110000-00007.
    51. Mah Z, Bryant H. Age as a factor in breast cancer knowledge, attitudes and screening behaviour. CMAJ (Can Med Assoc J): Can Med Assoc J 1992;146(12):2167.
    52. Luengo-Matos S, Polo-Santos M, Saz-Parkinson Z. Mammography use and factors associated with its use after the introduction of breast cancer screening programmes in Spain. Eur J Canc Prev 2006;15(3):242e8. https://doi.org/10.1097/01.cej.0000199503.30818.e6.
    53. Nembhard KTA. Knowledge of overdiagnosis and the decision to participate in breast cancer screening (Doctoral dissertation, Walden University). 2015. Retrieved from, http://scholarworks.waldenu.edu/cgi/viewcontent.cgi?article%1466&context%dissertations.
    54. Reder M, Kolip P. Does a decision aid improve informed choice in ammography screening? Results from a randomised controlled trial. PLoS One 2017;12(12), e0189148. https://doi.org/10.1371/journal.pone.0189148.
    55. Sommer R, Dirmaier J, Fechtelpeter D, Koch K, Hearter M, Bergelt C. Development of a decision tool for mammography screening. Onkologe 2016;22(8):578e85. Retrieved from, https://link.springer.com/article/10.1007/s00761-016-0081-x.
    56. Soskolne V, Marie S, Manor O. Beliefs, recommendations and intentions are important explanatory factors of mammography screening behavior among Muslim Arab women in Israel. Health Educ Res 2006;22(5):665e76. https://doi.org/10.1093/her/cyl132.
    57. van Agt H, Fracheboud J, van der Steen A, de Koning H. Do women make an informed choice about participating in breast cancer screening? A survey among women invited for a first mammography screening examination. Patient Educ Counsel 2012;89(2):353e9. https://doi.org/10.1016/j.pec.2012.08.003.
    58. Villanueva EV, Jones S, Nehill C, Favelle S, Steel D, Iverson D, Zorbas H. The 2003 Australian Breast Health Survey: survey design and preliminary results. BMC Publ Health 2008;8:13. https://doi.org/10.1186/1471-2458-8-13.
    59. Waller J, Whitaker KL, Winstanley K, Power E, Wardle J. A survey study of women’s responses to information about overdiagnosis in breast cancer screening in Britain. Br J Canc 2014;111(9):1831e5. https://doi.org/10.1038/bjc.2014.482.
    60. Al-Dubai SA, Qureshi AM, Saif-Ali R, Ganasegeran K, Alwan MR, Hadi JI. Awareness and knowledge of breast cancer and mammography among a group of Malaysian women in Shah Alam. Asian Pac J Cancer Prev APJCP 2011;12(10):2531e8. Retrieved from, http://apepressco.com/APJCP_Issues.php.
    61. King ES, Resch N, Rimer B, Lerman C, Boyce A, McGoverngorchov P. Breast cancer screening practices among retirement community women. Prev Med 1993;22(1):1e19. https://doi.org/10.1006/pmed.1993.1001.
    62. Sim HL, Seah M, Tan SM. Breast cancer knowledge and screening practices: a survey of 1,000 Asian women. Singap Med J 2009;50(2):132. Retrieved from, https://pdfs.semanticscholar.org/6bc0/9634124516a19112fb54c267d40bbbdbd7f9.pdf.
    63. Lagerlund M, Hedin A, Sparen P, Thurfjell E, Lambe M. Attitudes, beliefs, and knowledge as predictors of nonattendance in a Swedish population-based mammography screening program. Prev Med 2000;31(4):417e28. https:// doi.org/10.1006/pmed.2000.0723.
    64. Nekhlyudov L, Li R, Fletcher SW. Informed decision making before initiating screening mammography: does it occur and does it make a difference? Health Expect: Int J Public Part Health Care Health Policy 2008;11(4):366e75. https://doi.org/10.1111/j.1369-7625.2008.00514.x.
    65. Jørgensen KJ, Gøtzsche PC. Presentation on websites of possible benefits and harms from screening for breast cancer: cross sectional study. BMJ2004;328(7432):148. https://doi.org/10.1136/bmj.328.7432.148.
    66. Amoran O, Toyobo T, Fatugase O. Breast cancer screening awareness and practice among women in Sagamu local government area, South-Western Nigeria: a community based study. Br J Appl Sci Technol 2014;4(16):2320. https://doi.org/10.9734/bjast/2014/9050.
    67. Peppercorn J, Houck K, Beri N, Villagra V, Wogu AF, Lyman GH, Wheeler SB. Breast cancer screening utilization and understanding of current guidelines among rural US women with private insurance. Breast Canc Res Treat 2015;153(3):659e67. https://doi.org/10.1007/s10549-015-3566-1.
    68. McNair Ingenuity Research group. Campaign evaluation BreastScreen Australia. 2015. Retrieved from, http://www.cancerscreening.gov.au/internet/screening/publishing.nsf/Content/D2F8355B3C9C3107CA257E1A007D9F71/$File/BreastScreen%20Eval%20Report.pdf.
    69. Shapiro S, Venet W, Strax P, Venet L, Roeser R. Selection, follow-up, and analysis in the Health Insurance Plan Study: a randomized trial with breast cancer screening. Natl Canc Inst Monogr 1985;67:65e74. Retrieved from, http://europepmc.org/abstract/med/4047153.
    70. Bleyer A, Welch HG. Effect of three decades of screening mammography on breast-cancer incidence. N Engl J Med 2012;367(21):1998e2005. https://doi.org/10.1056/NEJMoa1206809.
    71. Ghanouni A, Renzi C, Meisel SF, Waller J. Common methods of measuring “informed choice” in screening participation: challenges and future directions. Prevent Med Rep 2016;4:601e7. https://doi.org/10.1016/j.pmedr.2016.10.017.
    1. Lau Y, Jaye C. The ‘obligation’ to screen and its effect on autonomy. J bioeth Inq 2009;6(4):495e505. https://doi.org/10.1007/s11673-009-9188-8.
    2. Seaman K, Dzidic P, Breen L, Saunders C. Exploring breast health practices of post-menopausal women: implications to informed consent. J Health Psychol https://doi.org/10.1177/1359105316669876. 135910531666987.
    3. Jones SC. Coverage of breast cancer in the Australian print media e does advertising and editorial coverage reflect correct social marketing messages? J Health Commun 2004;9(4):309e25. https://doi.org/10.1080/10810730490468441.
    4. Jørgensen KJ, Gøtzsche PC. Content of invitations for publicly funded screening mammography. BMJ 2006;332(7540):538e41. https://doi.org/10.1136/bmj.332.7540.538.
    5. Schwartz LM, Woloshin S, Fowler Jr FJ, Welch HG. Enthusiasm for cancer screening in the United States. Jama 2004;291(1):71e8. https://doi.org/10.1001/jama.291.1.71.
    6. Gigerenzer G. Public knowledge of benefits of breast and prostate cancer screening in Europe. Simply Rational 2015:94e104.
    1. World Health Organization. WHO position paper on mammography screening. World Health Organization; 2014. Retrieved from, http://apps.who. int/iris/bitstream/10665/137339/1/9789241507936_eng.pdf.
    2. Lauby-Secretan B, Scoccianti C, Loomis D, Benbrahim-Tallaa L, Bouvard V, Bianchini F, Straif K. Breast-cancer screeningdviewpoint of the IARC working group. N Engl J Med 2015;372(24):2353e8.
    3. Gøtzsche PC, Jørgensen KJ. Screening for breast cancer with mammography. Cochrane Database Syst Rev 2013;6(6). https://doi.org/10.1002/14651858.CD001877.pub2.
    4. Morris E, Feig SA, Drexler M, Lehman C. Implications of overdiagnosis: impact on screening mammography practices. Popul Health Manag 2015;18(Suppl 1). https://doi.org/10.1089/pop.2015.29023.mor. S-3-S-11.
    5. Armstrong K, Moye E, Williams S, Berlin JA, Reynolds EE. Screening mammography in women 40 to 49 years of age: a systematic review for the American College of Physicians. Ann Intern Med 2007;146(7):516e26. https://doi.org/10.7326/0003-4819-146-7-200704030-00008.
    6. Australian Institute of Health and Welfare. BreastScreen Australia monitoring report 2012e2013. Canberra: Author; 2015 (Cancer series no. 95. Cat. no. CAN 93).
    7. Griffiths F, Bendelow G, Green E, Palmer J. Screening for breast cancer: medicalization, visualization and the embodied experience. Health: Interdiscipl J Soc Stud Health Ill Med 2010;14(6):653e68. https://doi.org/10.1177/1363459310361599.
    8. Pace LE, Keating NL. A systematic assessment of benefits and risks to guide breast cancer screening decisions. J Am Med Assoc 2014;311(13):1327e35. https://doi.org/10.1001/jama.2014.1398.
    9. Mathieu E, Barratt AL, McGeechan K, Davey HM, Howard K, Houssami N. Helping women make choices about mammography screening: an online randomized trial of a decision aid for 40-year-old women. Patient Educ Counsel 2010;81(1):63e72. https://doi.org/10.1016/j.pec.2010.01.001.
    10. Nelson HD, Fu R, Cantor A, Pappas M, Daeges M, Humphrey L. Effectiveness of breast cancer screening: systematic review and meta-analysis to update the 2009 US Preventive Services Task Force recommendation. Ann Intern Med 2016;164(4):244e55. https://doi.org/10.7326/M15-0969.
    11. Siu AL. Screening for breast cancer: US preventive services task force recommendation statement. Ann Intern Med 2016;164(4):279e96. https://doi.org/10.7326/m15-2886.
    12. Marmot M, Altman D, Cameron D, et al. The benefits and harms of breast cancer screening: an independent review. Br J Canc 2013;108:2205e40. https://doi.org/10.1016/s0140-6736(12)61611-0.
    13. Jørgensen KJ, Gøtzsche PC. Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends. BMJ 2009;339, b2587. https://doi.org/10.1136/bmj.b2587.
    14. Brodersen J, Siersma VD. Long-term psychosocial consequences of false positive screening mammography. Ann Fam Med 2013;11(2):106e15. https://doi.org/10.1370/afm.1466.
    15. Salz T, Richman AR, Brewer NT. Meta-analyses of the effect of false- positive mammograms on generic and specific psychosocial outcomes. Psycho Oncol 2010;19(10):1026e34. https://doi.org/10.1002/pon.1676.
    16. Tosteson AN, Fryback DG, Hammond CS, Hanna LG, Grove MR, Brown M, …,Pisano ED. Consequences of false-positive screening mammograms. JAMA Int Med 2014;174(6):954e61. https://doi.org/10.1001/jamainternmed.2014.981.
    17. Yaffe MJ, Mainprize JG. Risk of radiation-induced breast cancer from mammographic screening 1. Radiology 2011;258(1):98e105. https://doi.org/10.1148/radiol.10100655.
    18. Chamot E, Perneger TV. Misconceptions about efficacy of mammography screening: a public health dilemma. J Epidemiol Community Health 2001;55(11):799e803. https://doi.org/10.1136/jech.55.11.799.
    19. Domenighetti G, D’Avanzo B, Egger M, Berrino F, Perneger T, Mosconi P, Zwahlen M. Women’s perception of the benefits of mammography screening: population-based survey in four countries. Int J Epidemiol 2003;32(5):816e21. https://doi.org/10.1093/ije/dyg257.
    20. Webster P, Austoker J. Women’s knowledge about breast cancer risk and their views of the purpose and implications of breast screeningda questionnaire survey. J Public Health 2006;28(3):197e202. https://doi.org/10.1093/pubmed/fdl030.
    21. Woloshin S, Schwartz LM, Byram SJ, Sox HC, Fischhoff B, Welch HG. Women’s understanding of the mammography screening debate. Arch Intern Med 2000;160(10):1434e40. https://doi.org/10.1001/archinte.160.10.1434.
    22. Hersch J, Barratt A, Jansen J, Irwig L, McGeechan K, Jacklyn G, …, McCaffery K. Use of a decision aid including information on overdetection to support informed choice about breast cancer screening: a randomised controlled trial. Lancet 2015;385(9978):1642e52. https://doi.org/10.1016/S0140-6736(15)60123-4.
    23. Hersch J, Jansen J, Barratt A, Irwig L, Houssami N, Jacklyn G, …, McCaffery K. Overdetection in breast cancer screening: development and preliminary evaluation of a decision aid. BMJ Open 2014;4(9):e006016. https://doi.org/10.1136/bmjopen-2014-006016.
    24. Waller J, Douglas E, Whitaker KL, Wardle J. Women ‘s responses to information about overdiagnosis in the UK breast cancer screening programme: a qualitative study. BMJ Open 2013;3(4). https://doi.org/10.1136/bmjopen2013-002703.
    25. Hersch J, Jansen J, Irwig L, Barratt A, Thornton H, Howard K, McCaffery K. Howdo we achieve informed choice for women considering breast screening? Prev Med 2011;53(3):144e6. https://doi.org/10.1016/j.ypmed.2011.06.013.
    26. Mathieu E, Barratt A, Davey HM, McGeechan K, Howard K, Houssami N. Informed choice in mammography screening: a randomized trial of a decision aid for 70-year-old women. Arch Intern Med 2007;167(19):2039e46. https://doi.org/10.1001/archinte.167.19.2039.
    27. Smith SK, Trevena L, Simpson JM, Barratt A, Nutbeam D, McCaffery KJ.A decision aid to support informed choices about bowel cancer screening among adults with low education: randomised controlled trial. BMJ 2010;341.https://doi.org/10.1136/bmj.c537.
    28. Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, Stewart LA. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev 2015;4(1):1. https://doi.org/10.1136/bmj.i4086.
    29. Kmet L, Lee R, Cook L. Standard quality assessment criteria for evaluating primary research papers from a variety of fields. 2004. Retrieved from https://www.biomedcentral.com/content/supplementary/1471-2393-14-52-s2.pdf.
    30. Lee L, Packer TL, Tang SH, Girdler S. Self-management education programs for age-related macular degeneration: a systematic review. Australas J Ageing 2008;27(4):170e6. https://doi.org/10.1111/j.1741-6612.2008.00298.x.
    31. Popay J, Roberts H, Sowden A, Petticrew M, Arai L, Rodgers M, …, Duffy S. Guidance on the conduct of narrative synthesis in systematic reviews: a product from the ESRC Methods Programme. Lancaster University; 2006.
    32. Achat H, Close G, Taylor R. Who has regular mammograms? Effects of knowledge, beliefs, socioeconomic status, and health-related factors. Prev Med 2005;41(1):312e20. https://doi.org/10.1016/j.ypmed.2004.11.016.
    33. Baena-Canada JM, Rosado-Varela P, Exposito-Alvarez I, Gonzalez-Guerrero M, Nieto-Vera J, Benitez-Rodriguez E. Women’s perceptions of breast cancer screening. Spanish screening programme survey. Breast 2014;23(6):883e8. https://doi.org/10.1016/j.breast.2014.09.010.
    34. Banning M. Perceptions of breast health awareness in Black British women. Eur J Oncol Nurs 2011;15(2):173e7. https://doi.org/10.1016/j.ejon.2010.07.007.
    35. Barratt A, Cockburn J, Furnival C, McBride A, Mallon L. Perceived sensitivity of mammographic screening: women’s views on test accuracy and financial compensation for missed cancers. J Epidemiol Community Health 1999;53(11):716e20. https://doi.org/10.1136/jech.53.11.716.
    36. Barratt AL, Cockburn J, Redman S, Paul C, Perkins J. Mammographic screening: results from the 1996 national breast health survey. Med J Aust 1997;167(10):521e4. Retrieved from, http://europepmc.org/abstract/med/9397038.
    37. Berens E-M, Reder M, Razum O, Kolip P, Spallek J. Informed choice in the German Mammography Screening Program by education and migrant status: survey among first-time invitees. PLoS One 2015;10(11), e0142316. https://doi.org/10.1371/journal.pone.0142316.
    38. Berens EM, Yilmaz-Aslan Y, Spallek J, Razum O. Determinants of mammography screening participation among Turkish immigrant women in Germanyea qualitative study reflecting key informants’ and women’s perspectives. Eur J Canc Care 2016;25(1):38e48. https://doi.org/10.1111/ecc.12334.
    39. Chamot E, Charvet AI, Perneger TV. Who gets screened, and where: a comparison of organised and opportunistic mammography screening in Geneva, Switzerland. Eur J Canc 2007;43(3):576e84. https://doi.org/10.1016/j.ejca.2006.10.017.
    40. Chouliara Z, Power KG, Swanson V, Johnstone F. Factors associated with breast screening attendance: a controlled comparison between attenders and 92 K. Seaman et al. / The Breast 42 (2018) 81e93 nonattenders in Scotland. Int J Health Promot Educ 2002;40(3):78e90. https://doi.org/10.1080/14635240.2002.10806203.
    41. Cockburn J, Redman S, Hill D, Henry E. Public understanding of medical screening. J Med Screen 1995;2(4):224e7. https://doi.org/10.1177/096914139500200410.
    42. Cockburn J, Pit S, Redman S. Perceptions of screening mammography among women aged 40-49. Aust N Z J Publ Health 1999;23(3):318e21. https://doi.org/10.1111/j.1467-842x.1999.tb01264.x.
    43. Ferrat E, Le Breton J, Djassibel M, Veerabudun K, Brixi Z, Attali C, Renard V. Understanding barriers to organized breast cancer screening in France: women’s perceptions, attitudes, and knowledge. Fam Pract 2013;30(4):445e51. https://doi.org/10.1093/fampra/cmt004.
    44. Ham OK. Factors affecting mammography behavior and intention among Korean women. Oncol Nurs Forum 2006;33(1):113e9. https://doi.org/10.1188/06.onf.113-119.
    45. Henriksen MJV, Guassora AD, Brodersen J. Preconceptions influence women’s perceptions of information on breast cancer screening: a qualitative study. BMC Res Notes 2015;8(1). https://doi.org/10.1186/s13104-015-1327-1.
    46. Hersch J, Jansen J, Barratt A, Irwig L, Houssami N, Howard K, …, McCaffery K. Women’s views on overdiagnosis in breast cancer screening: a qualitative study. BMJ (Clinical research ed.) 2013;346:1. https://doi.org/10.1136/bmj.f158.
    47. Hippman C, Moshrefzadeh A, Lohn Z, Hodgson ZG, Dewar K, Lam M, …, Kwong J. Breast cancer and mammography screening: knowledge, beliefs and predictors for Asian immigrant women attending a specialized clinic in British Columbia, Canada. J Immigr Minority Health 2015;18(6):1441e8. https://doi.org/10.1007/s10903-015-0332-8.
    48. Kissal A, Beser A. Knowledge, facilitators and perceived barriers for early detection of breast cancer among elderly Turkish women. Asian Pac J Cancer Prev APJCP 2011;12(4):975e84. Retrieved from, https://www.ncbi.nlm.nih.gov/pubmed/21790237.
    49. Kwok C, Lim D. Evaluation of a culturally tailored education to promote breast and cervical cancer screening among Chinese-Australian women. J Canc Educ 2015;31(3):595e601. https://doi.org/10.1007/s13187-015-0859-3.
    50. Lagerlund M, Widmark C, Lambe M, Tishelman C. Rationales for attending or not attending mammography screening – a focus group study among women in Sweden. Eur J Canc Prev 2001;10(5):429e42. https://doi.org/10.1097/00008469-200110000-00007.
    51. Mah Z, Bryant H. Age as a factor in breast cancer knowledge, attitudes and screening behaviour. CMAJ (Can Med Assoc J): Can Med Assoc J 1992;146(12):2167.
    52. Luengo-Matos S, Polo-Santos M, Saz-Parkinson Z. Mammography use and factors associated with its use after the introduction of breast cancer screening programmes in Spain. Eur J Canc Prev 2006;15(3):242e8. https://doi.org/10.1097/01.cej.0000199503.30818.e6.
    53. Nembhard KTA. Knowledge of overdiagnosis and the decision to participate in breast cancer screening (Doctoral dissertation, Walden University). 2015. Retrieved from, http://scholarworks.waldenu.edu/cgi/viewcontent.cgi?article%1466&context%dissertations.
    54. Reder M, Kolip P. Does a decision aid improve informed choice in ammography screening? Results from a randomised controlled trial. PLoS One 2017;12(12), e0189148. https://doi.org/10.1371/journal.pone.0189148.
    55. Sommer R, Dirmaier J, Fechtelpeter D, Koch K, Hearter M, Bergelt C. Development of a decision tool for mammography screening. Onkologe 2016;22(8):578e85. Retrieved from, https://link.springer.com/article/10.1007/s00761-016-0081-x.
    56. Soskolne V, Marie S, Manor O. Beliefs, recommendations and intentions are important explanatory factors of mammography screening behavior among Muslim Arab women in Israel. Health Educ Res 2006;22(5):665e76. https://doi.org/10.1093/her/cyl132.
    57. van Agt H, Fracheboud J, van der Steen A, de Koning H. Do women make an informed choice about participating in breast cancer screening? A survey among women invited for a first mammography screening examination. Patient Educ Counsel 2012;89(2):353e9. https://doi.org/10.1016/j.pec.2012.08.003.
    58. Villanueva EV, Jones S, Nehill C, Favelle S, Steel D, Iverson D, Zorbas H. The 2003 Australian Breast Health Survey: survey design and preliminary results. BMC Publ Health 2008;8:13. https://doi.org/10.1186/1471-2458-8-13.
    59. Waller J, Whitaker KL, Winstanley K, Power E, Wardle J. A survey study of women’s responses to information about overdiagnosis in breast cancer screening in Britain. Br J Canc 2014;111(9):1831e5. https://doi.org/10.1038/bjc.2014.482.
    60. Al-Dubai SA, Qureshi AM, Saif-Ali R, Ganasegeran K, Alwan MR, Hadi JI. Awareness and knowledge of breast cancer and mammography among a group of Malaysian women in Shah Alam. Asian Pac J Cancer Prev APJCP 2011;12(10):2531e8. Retrieved from, http://apepressco.com/APJCP_Issues.php.
    61. King ES, Resch N, Rimer B, Lerman C, Boyce A, McGoverngorchov P. Breast cancer screening practices among retirement community women. Prev Med 1993;22(1):1e19. https://doi.org/10.1006/pmed.1993.1001.
    62. Sim HL, Seah M, Tan SM. Breast cancer knowledge and screening practices: a survey of 1,000 Asian women. Singap Med J 2009;50(2):132. Retrieved from, https://pdfs.semanticscholar.org/6bc0/9634124516a19112fb54c267d40bbbdbd7f9.pdf.
    63. Lagerlund M, Hedin A, Sparen P, Thurfjell E, Lambe M. Attitudes, beliefs, and knowledge as predictors of nonattendance in a Swedish population-based mammography screening program. Prev Med 2000;31(4):417e28. https:// doi.org/10.1006/pmed.2000.0723.
    64. Nekhlyudov L, Li R, Fletcher SW. Informed decision making before initiating screening mammography: does it occur and does it make a difference? Health Expect: Int J Public Part Health Care Health Policy 2008;11(4):366e75. https://doi.org/10.1111/j.1369-7625.2008.00514.x.
    65. Jørgensen KJ, Gøtzsche PC. Presentation on websites of possible benefits and harms from screening for breast cancer: cross sectional study. BMJ2004;328(7432):148. https://doi.org/10.1136/bmj.328.7432.148.
    66. Amoran O, Toyobo T, Fatugase O. Breast cancer screening awareness and practice among women in Sagamu local government area, South-Western Nigeria: a community based study. Br J Appl Sci Technol 2014;4(16):2320. https://doi.org/10.9734/bjast/2014/9050.
    67. Peppercorn J, Houck K, Beri N, Villagra V, Wogu AF, Lyman GH, Wheeler SB. Breast cancer screening utilization and understanding of current guidelines among rural US women with private insurance. Breast Canc Res Treat 2015;153(3):659e67. https://doi.org/10.1007/s10549-015-3566-1.
    68. McNair Ingenuity Research group. Campaign evaluation BreastScreen Australia. 2015. Retrieved from, http://www.cancerscreening.gov.au/internet/screening/publishing.nsf/Content/D2F8355B3C9C3107CA257E1A007D9F71/$File/BreastScreen%20Eval%20Report.pdf.
    69. Shapiro S, Venet W, Strax P, Venet L, Roeser R. Selection, follow-up, and analysis in the Health Insurance Plan Study: a randomized trial with breast cancer screening. Natl Canc Inst Monogr 1985;67:65e74. Retrieved from, http://europepmc.org/abstract/med/4047153.
    70. Bleyer A, Welch HG. Effect of three decades of screening mammography on breast-cancer incidence. N Engl J Med 2012;367(21):1998e2005. https://doi.org/10.1056/NEJMoa1206809.
    71. Ghanouni A, Renzi C, Meisel SF, Waller J. Common methods of measuring “informed choice” in screening participation: challenges and future directions. Prevent Med Rep 2016;4:601e7. https://doi.org/10.1016/j.pmedr.2016.10.017.
    72. Lau Y, Jaye C. The ‘obligation’ to screen and its effect on autonomy. J bioeth Inq 2009;6(4):495e505. https://doi.org/10.1007/s11673-009-9188-8.
    73. Seaman K, Dzidic P, Breen L, Saunders C. Exploring breast health practices of post-menopausal women: implications to informed consent. J Health Psychol https://doi.org/10.1177/1359105316669876. 135910531666987.
    74. Jones SC. Coverage of breast cancer in the Australian print media e does advertising and editorial coverage reflect correct social marketing messages? J Health Commun 2004;9(4):309e25. https://doi.org/10.1080/10810730490468441.
    75. Jørgensen KJ, Gøtzsche PC. Content of invitations for publicly funded screening mammography. BMJ 2006;332(7540):538e41. https://doi.org/10.1136/bmj.332.7540.538.
    76. Schwartz LM, Woloshin S, Fowler Jr FJ, Welch HG. Enthusiasm for cancer screening in the United States. Jama 2004;291(1):71e8. https://doi.org/10.1001/jama.291.1.71.
    77. Gigerenzer G. Public knowledge of benefits of breast and prostate cancer screening in Europe. Simply Rational 2015:94e104.